Home/Filings/4/0001437749-19-017324
4//SEC Filing

FERNANDEZ FERNANDO L 4

Accession 0001437749-19-017324

CIK 0000925741other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 6:04 AM ET

Size

11.9 KB

Accession

0001437749-19-017324

Insider Transaction Report

Form 4
Period: 2019-01-13
BioCardia, Inc.BCDA;BCDAW
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2019-07-263,594567 total
    Exercise: $0.00Common Stock (3,594 underlying)
  • Exercise/Conversion

    Common Stock

    2019-01-13+5672,154 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-01-135674,161 total
    Exercise: $0.00Common Stock (567 underlying)
  • Exercise/Conversion

    Common Stock

    2019-07-26+3,5945,748 total
Footnotes (6)
  • [F1]Represents the conversion upon vesting of restricted stock units ("RSUs") into common stock. On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017) that were previously reported on Table II of Form 4, which form was filed with the Securities and Exchange Commission (the "SEC") on January 18, 2017.
  • [F2]Represents the conversion upon vesting of RSUs into common stock. On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018.
  • [F3]The converted RSU corresponds to a 1:1 common stock issuance.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F5]On January 13, 2017, the reporting person was granted 184,000 RSUs (1,703 after the 1-for-9 reverse stock split effective May 7, 2019 and the 1-for-12 reverse split effective November 2, 2017), of which 567 vested on January 13, 2019. The common stock into which such vested RSUs converted on January 13, 2019 is reported on Table I of this Form 4. The remaining RSUs will vest on the third one-year anniversary of the grant date, subject to the Reporting Person continuing as a service provider through such date.
  • [F6]On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019. The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4.

Issuer

BioCardia, Inc.

CIK 0000925741

Entity typeother

Related Parties

1
  • filerCIK 0001214346

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 6:04 AM ET
Size
11.9 KB